GNQ Insilico Secures MindLab, an Award Winning Pharma Company, as a Client for its Drug Assessment Platform
GNQ Insilico’s Quantum-enhanced and AI-powered Platform to Accelerate Development of MindLab’s Novel Pain Management Therapy PLEASANTON, CA, UNITED STATES, October 30, 2025 /EINPresswire.com/ — GNQ Insilico Inc., a pioneer in quantum-enhanced AI drug development, is pleased to announce a strategic partnership with MindLab, LLC to deploy its newly launched Drug Assessment Platform (DAP) to accelerate […]
